Our Products
Engage HCPs on demand, connecting them to valuable brand resources through dynamic, AI-powered technology.
Pulse
High-impact
messages that can span any point of a brand lifecycle.
Personalized
Extension
reach to hard-to-engage HCPs uniquely found in the Impiricus network.
Precise
targeting and NPI-level reporting with PLD passed back.
Guaranteed delivery of relevant, value-based communication to your HCP audiences through our next generation engine.
98%
open rate on average
6x
higher CTR than email
~30%
of HCPs only engaging via SMS
>10:1
ROI achieved consistently
Spark
Trigger personalized messaging powered by marketing or clinical activity for competitive markets, rare disease, HCP education, and more.
A relevant action creates a relevant message.
Spark can trigger engagements off custom datasets and Next Best Action Engines.
Clinical Triggers
• Prescription Activity
• Lab Orders and Results
• New Diagnosis Codes
Marketing Triggers
• Email Engagement
• Link Clicks
• Website Visits
Impiricus designs and delivers bespoke messaging journeys across brands and manufacturers.
95%
of SMS messages are opened within 3 minutes
5-10x
faster impact than other channels for triggered engagement.
96x
5.5
hours spent on mobile device every day on average.
Ascend
AI field force enhancement connecting HCPs to reps and brand resources in real-time.
Real time engagement
Seamless
Integrate with your existing CRM and resource management tools for a comprehensive and efficient workflow.
Custom
Experience a bespoke and customized partnership with an end-to-end product tailored to meet your unique needs.
Real-time
Engage your target & white-space HCPs in multichannel conversations through SMS, voice calls, email, and more, providing a versatile and adaptive strategy.
Providing personalized HCP support for non- and low-prescribers of a top brand drove:
$6.9M
of incremental revenue within 2 months.
35.9%
more NRx from previous non-prescribers.
800
new prescribers.
News And Insights
Impiricus CEO Sandy Donaldson on the Future of Pharma Marketing Amid Potential TV Ad Ban
